Please sign in with your existing account details.
Register to access exclusive content, sign up to receive our updates and personalise your experience on brownejacobson.com.
Privacy statement - Terms and conditions
Forgotten your password?
You have exceeded the maximum number of login attempts for this email address and your account has been locked. An email has been sent to member of Browne Jacobson's web team and some one will be contacting you over the next two working days with details of how to change your password.
Are you sure you want to remove this item from you pinned content?
London Oratory School, a heavily oversubscribed comprehensive catholic boys school, has been ordered to amend its admission policy by the Schools Adjudicator as it breached the School Admissions Code 2012. The Adjudicator decided that the priority given to children at the school, where there was evidence of at least three years service to the local church community was unfair in that it disadvantaged those who were not good at planning ahead or those who had moved into the area and were unaware of these requirements.
Whilst the school may choose to challenge the decision, as has happened before, the case does highlight the need for schools to carefully review their admission policies in light of the School Admissions Code 2012 and ensure that the policy is clear, fair and objective and, as far as possible, meets the needs of the community the school serves. Where policies fall short of this standard, the report shows that changes may be forced upon schools against their wishes.
With the Prime Ministers announcement that he intends for Step 4 to begin on 19 July, this will also bring an end to the restrictions currently in place on education settings.
View blog
The issue of Female Genital Mutilation Protection Orders and the importance of education providers to act promptly.
Our top tips for supporting transgender and non-binary pupils.
On 4 June, the Medicines and Healthcare products Regulatory Agency (MHRA) approved the use of the Pfizer/BioNTech Covid-19 vaccine for 12- to 15-year-olds.
Partner
Select which mailings you would like to receive from us.
Sign up